Frontlight ResearchEarly access
Trial site
National Taiwan University Hospital - Hsinchu branch
- 10running trials
- 1closed trial
The trials here
What the 11 trials at this site are about, from their registry records.
- Conditions
- Atopic dermatitis (eczema)2 trials
- Chronic kidney disease2 trials
- COPD2 trials
- Heart failure2 trials
- Colorectal cancer1 trial
- Glaucoma1 trial
- High blood pressure1 trial
- Lung cancer1 trial
- Phase
- Phase 33 trials
- Phase 42 trials
- Phase 2/31 trial
- Status
- Recruiting8 trials
- Active, not recruiting1 trial
- Completed1 trial
- Enrolling by invitation1 trial
- Lead sponsor
- National Taiwan University Hospital7 trials
- Eli Lilly and Company2 trials
- Pfizer2 trials
Running trials
Recruiting
ULTRA-high-risk Surveillance to Avoid Future Events: the ULTRA-SAFE Trial
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Empagliflozin in Heart Failure With Reduced Ejection Fraction and End Stage Renal Disease
Recruiting
EMPAgliflozin in Heart Failure With PReserved Ejection Fraction and End Stage Renal Disease
Recruiting
Enrolling by invitation
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Chronic kidney disease2 recruiting
- COPD2 recruiting
- Heart failure2 recruiting
- Atopic dermatitis (eczema)1 recruiting
- Colorectal cancer1 recruiting
- Glaucoma1 recruiting
- High blood pressure1 recruiting
- Lung cancer1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 17 Nov 2026